Yeung Ho

20152020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Diverse AR gene rearrangements mediate resistance to androgen receptor inhibitors in metastatic prostate cancer

Li, Y., Yang, R., Henzler, C. M., Ho, Y., Passow, C., Auch, B., Carreira, S., Rodrigues, D. N., Bertan, C., Hwang, T. H., Quigley, D. A., Dang, H. X., Morrissey, C., Fraser, M., Plymate, S. R., PlymateMaher, C. A., Feng, F. Y., De Bono, J. S. & Dehm, S. M., Apr 15 2020, In : Clinical Cancer Research. 26, 8, p. 1965-1976 12 p.

Research output: Contribution to journalArticle

Open Access
  • Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer

    Zadra, G., Ribeiro, C. F., Chetta, P., Ho, Y., Cacciatore, S., Gao, X., Syamala, S., Bango, C., Photopoulos, C., Huang, Y., Tyekucheva, S., Bastos, D. C., Tchaicha, J., Lawney, B., Uo, T., D’Anello, L., Csibi, A., Kalekar, R., Larimer, B., Ellis, L. & 12 others, Butler, L. M., Morrissey, C., McGovern, K., Palombella, V. J., Kutok, J. L., Mahmood, U., Bosari, S., Adams, J., Peluso, S., Dehm, S. M., Plymate, S. R. & Loda, M., Jan 8 2019, In : Proceedings of the National Academy of Sciences of the United States of America. 116, 2, p. 631-640 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • 31 Scopus citations

    Androgen receptor rearrangement and splicing variants in resistance to endocrine therapies in prostate cancer

    Ho, Y. & Dehm, S. M., Jun 1 2017, In : Endocrinology. 158, 6, p. 1533-1542 10 p.

    Research output: Contribution to journalReview article

    Open Access
  • 26 Scopus citations

    Androgen receptor variant AR-V9 is coexpressed with AR-V7 in prostate cancer metastases and predicts abiraterone resistance

    Kohli, M., Ho, Y., Hillman, D. W., Van Etten, J. L., Henzler, C., Yang, R., Sperger, J. M., Li, Y., Tseng, E., Hon, T., Clark, T., Tan, W., Carlson, R. E., Wang, L., Sicotte, H., Thai, H., Jimenez, R., Huang, H., Vedell, P. T., Eckloff, B. W. & 9 others, Quevedo, J. F., Pitot, H. C., Costello, B. A., Jen, J., Wieben, E. D., Silverstein, K. A. T., Lang, J. M., Wang, L. & Dehm, S. M., Aug 15 2017, In : Clinical Cancer Research. 23, 16, p. 4704-4715 12 p.

    Research output: Contribution to journalArticle

    Open Access
  • 51 Scopus citations

    Targeting a single alternative polyadenylation site coordinately blocks expression of androgen receptor mRNA splice variants in prostate cancer

    Van Etten, J. L., Nyquist, M., Li, Y., Yang, R., Ho, Y., Johnson, R., Ondigi, O., Voytas, D. F., Henzler, C. & Dehm, S. M., Oct 1 2017, In : Cancer Research. 77, 19, p. 5228-5235 8 p.

    Research output: Contribution to journalArticle

    Open Access
  • 19 Scopus citations